Sign In

Login

Password

Forgot Password ? Sign Up

ヌシネルセン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ヌシネルセン" in Japanese language version.

refsWebsite
Global rank Japanese rank
8nih.gov
4th place
24th place
2doi.org
2nd place
6th place
2worldcat.org
5th place
19th place
1who.int
195th place
376th place
1fda.gov
447th place
1,043rd place
1springer.com
274th place
596th place
1biogen.co.jp
low place
low place
1sciencemag.org
857th place
1,005th place
1the-scientist.com
7,827th place
low place
1cshl.edu
low place
low place
1curesma.org
low place
low place
1genengnews.com
low place
low place
1biogen.com
low place
low place
1smanewstoday.com
low place
low place
1nytimes.com
7th place
63rd place
1wsj.com
79th place
235th place
1europa.eu
68th place
425th place
1afp.com
6,649th place
low place
1sps.nhs.uk
low place
low place
1fiercebiotech.com
low place
low place

afp.com

biogen.co.jp

biogen.com

media.biogen.com

cshl.edu

curesma.org

doi.org

  • Ottesen, Eric W. (2017-01-01). “ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy” (英語). Translational Neuroscience 8 (1): 1-6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976. https://doi.org/10.1515/tnsci-2017-0001. 
  • Garber, K (11 October 2016). “Big win possible for Ionis/Biogen antisense drug in muscular atrophy.”. Nature Biotechnology 34 (10): 1002-1003. doi:10.1038/nbt1016-1002. PMID 27727217. 

europa.eu

ema.europa.eu

fda.gov

accessdata.fda.gov

fiercebiotech.com

genengnews.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Ottesen, Eric W. (2017-01-01). “ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy” (英語). Translational Neuroscience 8 (1): 1-6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976. https://doi.org/10.1515/tnsci-2017-0001. 
  • Brain Dev. 2014 Nov;36(10):914-20. PMID 24359787
  • Genes Dev. 2010 Aug 1;24(15):1634-44. PMID 20624852
  • J Med Chem. 2016 Nov 23;59(22):10067-10083. PMID 27490705
  • N Engl J Med. 2017 Nov 2;377(18):1723-1732. PMID 29091570
  • N Engl J Med. 2018 Feb 15;378(7):625-635. PMID 29443664
  • Garber, K (11 October 2016). “Big win possible for Ionis/Biogen antisense drug in muscular atrophy.”. Nature Biotechnology 34 (10): 1002-1003. doi:10.1038/nbt1016-1002. PMID 27727217. 

pmc.ncbi.nlm.nih.gov

  • Ottesen, Eric W. (2017-01-01). “ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy” (英語). Translational Neuroscience 8 (1): 1-6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976. https://doi.org/10.1515/tnsci-2017-0001. 

nytimes.com

sciencemag.org

smanewstoday.com

springer.com

adisinsight.springer.com

  • “Nusinersen”. AdisInsight. 1 January 2017閲覧。

sps.nhs.uk

  • “Nusinersen”. UK Specialist Pharmacy Service. 31 December 2016閲覧。

the-scientist.com

who.int

worldcat.org

search.worldcat.org

  • Ottesen, Eric W. (2017-01-01). “ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy” (英語). Translational Neuroscience 8 (1): 1-6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976. https://doi.org/10.1515/tnsci-2017-0001. 
  • Grant, Charley (2016年12月27日). “Surprise Drug Approval Is Holiday Gift for Biogen”. Wall Street Journal. ISSN 0099-9660. https://www.wsj.com/articles/surprise-drug-approval-is-holiday-gift-for-biogen-1482856447 2016年12月27日閲覧。 

wsj.com